Gene · 8739
Papers1,778
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,778
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia. | Leukemia | 2022 | 35411095 | PubTator, text mining | PubMed |
| The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments. | Fluids Barriers CNS | 2022 | 35410231 | PubTator, text mining | PubMed |
| First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers. | Int J Mol Sci | 2022 | 35409311 | PubTator, text mining | PubMed |
| BECLIN1 Is Essential for Podocyte Secretory Pathways Mediating VEGF Secretion and Podocyte-Endothelial Crosstalk. | Int J Mol Sci | 2022 | 35409185 | PubTator, text mining | PubMed |
| Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia-The State-of-the-Art Knowledge and Future Prospects. | Int J Mol Sci | 2022 | 35409154 | PubTator, text mining | PubMed |
| Metazoans and Intrinsic Apoptosis: An Evolutionary Analysis of the Bcl-2 Family. | Int J Mol Sci | 2022 | 35409052 | PubTator, text mining | PubMed |
| Refining AML Treatment: The Role of Genetics in Response and Resistance Evaluation to New Agents. | Cancers (Basel) | 2022 | 35406464 | PubTator, text mining | PubMed |
| PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? | Front Oncol | 2022 | 35402264 | PubTator, text mining | PubMed |
| Integrated Analysis of Competitive Endogenous RNA Networks in Acute Ischemic Stroke. | Front Genet | 2022 | 35401659 | PubTator, text mining | PubMed |
| MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment. | Cell Death Discov | 2022 | 35393436 | PubTator, text mining | PubMed |
| Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity. | Front Immunol | 2022 | 35392102 | PubTator, text mining | PubMed |
| Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials. | J Immunother Cancer | 2022 | 35383114 | PubTator, text mining | PubMed |
| The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients. | Cell Mol Gastroenterol Hepatol | 2022 | 35378331 | PubTator, text mining | PubMed |
| Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies. | Signal Transduct Target Ther | 2022 | 35370290 | PubTator, text mining | PubMed |
| BAP31 Regulates Wnt Signaling to Modulate Cell Migration in Lung Cancer. | Front Oncol | 2022 | 35359416 | PubTator, text mining | PubMed |
| Efficiency of antioxidant Avenanthramide-C on high-dose methotrexate-induced ototoxicity in mice. | PLoS One | 2022 | 35353852 | PubTator, text mining | PubMed |
Development of the Validated Stability-Indicating Method for the Determination of Vortioxetine in Bulk and Pharmaceutical Formulation by HPLC-DAD, Stress Degradation Kinetics Studies and Detection of Degradation Products by LC-ESI-QTOF-MS. | Molecules | 2022 | 35335245 | PubTator, text mining | PubMed |
| Modulation of the Epithelial-Immune Cell Crosstalk and Related Galectin Secretion by DP3-5 Galacto-Oligosaccharides and β-3'Galactosyllactose. | Biomolecules | 2022 | 35327576 | PubTator, text mining | PubMed |
| Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay. | Biomedicines | 2022 | 35327406 | PubTator, text mining | PubMed |
| Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components. | Cancers (Basel) | 2022 | 35326612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8739/papers?page=17